(CENT) Central Garden & Pet - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NASDAQ (USA) | Market Cap: 2.414m USD | Total Return: 5.8% in 12m
Avg Turnover: 2.14M
EPS Trend: 88.5%
Qual. Beats: 1
Rev. Trend: -88.4%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Central Garden & Pet Company (CENT) operates in the pet and garden supply markets. The companys business model involves manufacturing and distributing a diverse range of products across two primary segments.
The Pet segment offers supplies for various animals, including dogs, cats, small animals, and aquatics. Products include treats, toys, bedding, and health-related items, sold under brands like Aqueon and Nylabone. This segment addresses consumer demand for pet care products, a market driven by pet ownership trends.
The Garden segment focuses on lawn and garden supplies. Offerings include seeds, bird feed, fertilizers, and pest control products, with brands such as Pennington and Sevin. This segment serves the home gardening and outdoor living market.
CENT distributes its products through multiple channels, including independent distributors, large retailers, and e-commerce platforms. This multi-channel approach is common for consumer goods companies to maximize market reach. Further analysis of CENTs financial performance and market position can be found on ValueRay.
- Pet segment product demand drives revenue growth
- Garden segment seasonal sales impact profitability
- Raw material and freight costs compress margins
- Retailer consolidation affects distribution channels
- Weather patterns influence garden product sales
| Net Income: 171.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.64 > 1.0 |
| NWC/Revenue: 46.88% < 20% (prev 43.65%; Δ 3.22% < -1%) |
| CFO/TA 0.09 > 3% & CFO 328.3m > Net Income 171.5m |
| Net Debt (974.9m) to EBITDA (363.5m): 2.68 < 3 |
| Current Ratio: 3.45 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.9m) vs 12m ago -4.53% < -2% |
| Gross Margin: 32.21% > 18% (prev 0.30%; Δ 3.19k% > 0.5%) |
| Asset Turnover: 85.76% > 50% (prev 86.95%; Δ -1.18% > 0%) |
| Interest Coverage Ratio: 4.88 > 6 (EBITDA TTM 363.5m / Interest Expense TTM 57.3m) |
| A: 0.40 (Total Current Assets 2.09b - Total Current Liabilities 605.2m) / Total Assets 3.75b |
| B: 0.29 (Retained Earnings 1.09b / Total Assets 3.75b) |
| C: 0.08 (EBIT TTM 279.8m / Avg Total Assets 3.69b) |
| D: 0.52 (Book Value of Equity 1.08b / Total Liabilities 2.09b) |
| Altman-Z'' = 4.60 = AA |
| DSRI: 1.04 (Receivables 603.2m/578.9m, Revenue 3.16b/3.16b) |
| GMI: 0.93 (GM 32.21% / 30.00%) |
| AQI: 0.99 (AQ_t 0.29 / AQ_t-1 0.30) |
| SGI: 1.00 (Revenue 3.16b / 3.16b) |
| TATA: -0.04 (NI 171.5m - CFO 328.3m) / TA 3.75b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of May 27, 2026, the stock is trading at USD 38.77 with a total of 65,008 shares traded.
Over the past week, the price has changed by +0.54%,
over one month by +1.87%,
over three months by -1.22% and
over the past year by +5.84%.
Central Garden & Pet has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CENT.
- StrongBuy: 3
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 48 | 23.8% |
P/E Trailing = 14.0291
P/E Forward = 11.8483
P/S = 0.7633
P/B = 1.4631
P/EG = 2.0079
Revenue TTM = 3.16b USD
EBIT TTM = 279.8m USD
EBITDA TTM = 363.5m USD
Long Term Debt = 1.19b USD (from longTermDebt, last quarter)
Short Term Debt = 51.6m USD (from shortTermDebt, last quarter)
Debt = 1.64b USD (from shortLongTermDebtTotal, last quarter) + Leases 225.9m
Net Debt = 974.9m USD (calculated: Debt 1.64b - CCE 669.4m)
Enterprise Value = 3.39b USD (2.41b + Debt 1.64b - CCE 669.4m)
Interest Coverage Ratio = 4.88 (Ebit TTM 279.8m / Interest Expense TTM 57.3m)
EV/FCF = 12.00x (Enterprise Value 3.39b / FCF TTM 282.4m)
FCF Yield = 8.33% (FCF TTM 282.4m / Enterprise Value 3.39b)
FCF Margin = 8.93% (FCF TTM 282.4m / Revenue TTM 3.16b)
Net Margin = 5.42% (Net Income TTM 171.5m / Revenue TTM 3.16b)
Gross Margin = 32.21% ((Revenue TTM 3.16b - Cost of Revenue TTM 2.14b) / Revenue TTM)
Gross Margin QoQ = 33.06% (prev 30.87%)
Tobins Q-Ratio = 0.90 (Enterprise Value 3.39b / Total Assets 3.75b)
Interest Expense / Debt = 3.48% (Interest Expense 57.3m / Debt 1.64b)
Taxrate = 23.47% (24.5m / 104.5m)
NOPAT = 214.1m (EBIT 279.8m * (1 - 23.47%))
Current Ratio = 3.45 (Total Current Assets 2.09b / Total Current Liabilities 605.2m)
Debt / Equity = 1.00 (Debt 1.64b / totalStockholderEquity, last quarter 1.65b)
Debt / EBITDA = 2.68 (Net Debt 974.9m / EBITDA 363.5m)
Debt / FCF = 3.45 (Net Debt 974.9m / FCF TTM 282.4m)
Total Stockholder Equity = 1.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.65% (Net Income 171.5m / Total Assets 3.75b)
RoE = 10.72% (Net Income TTM 171.5m / Total Stockholder Equity 1.60b)
RoCE = 10.02% (EBIT 279.8m / Capital Employed (Equity 1.60b + L.T.Debt 1.19b))
RoIC = 6.71% (NOPAT 214.1m / Invested Capital 3.19b)
WACC = 5.23% (E(2.41b)/V(4.06b) * Re(6.98%) + D(1.64b)/V(4.06b) * Rd(3.48%) * (1-Tc(0.23)))
Discount Rate = 6.98% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -51.11 | Cagr: 6.79%
[DCF] Terminal Value 73.10% ; FCFF base≈302.7m ; Y1≈265.4m ; Y5≈214.5m
[DCF] Fair Price = 255.7 (EV 3.44b - Net Debt 974.9m = Equity 2.47b / Shares 9.65m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 88.46 | EPS CAGR: 12.16% | SUE: 2.23 | # QB: 1
Revenue Correlation: -88.42 | Revenue CAGR: -2.47% | SUE: 2.21 | # QB: 1
EPS current Quarter (2026-06-30): EPS=1.52 | Chg30d=-4.05% | Revisions=-25% | Analysts=5
EPS current Year (2026-09-30): EPS=2.98 | Chg30d=+4.87% | Revisions=+56% | GrowthEPS=+9.0% | GrowthRev=-2.7%
EPS next Year (2027-09-30): EPS=3.10 | Chg30d=+3.52% | Revisions=+33% | GrowthEPS=+4.0% | GrowthRev=-3.2%
[Analyst] Revisions Ratio: +56%